53 Results for "

H37Rv strain

" in MedChemExpress (MCE) Product Catalog:
Products (53)

53 Results for "H37Rv strain" in MCE Product Catalog:

13
13 Cited Publications
Cat. No.: HY-B1046
CAS No.: 2030-63-9
Clofazimine is an orally-active anti-mycobacterial agent with a wide range of anti-mycobacterial activity including leprosy and tuberculosis. Clofazimine exerts anti-inflammatory activities and anti-tumor activities by interfering DNA replication and inhibiting IL2 (IC50 = 1.10 ± 0.26 μM, Jurkat T) production. Clofazimine can be used in mycobacterial and cancer research .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-111747
CAS No.: 2252316-16-6
Purity:  95.07%
Target:  

Bacterial

Research Areas:  

Infection Cardiovascular Disease

TBAJ-587, a potent anti-tuberculosis agent, inhibits M.tb strain H37Rv growth with MIC90s of 0.006 and <0.02 μg/mL in MABA and LORA assay, respectively. TBAJ-587 inhibits hERG channel minimally, attenuates inhibition of the cardiac potassium channel protein coded by the hERG, which is important for cardiac repolarization .
loading...
    loading...
Cat. No.: HY-125785A
CAS No.: 3811-73-2
Purity:  ≥98.0%
Target:  

Bacterial

Research Areas:  

Infection

2-Mercaptopyridine N-oxide sodium has bactericidal effect and is against a standard strain of Mycobacterium tuberculosis H37Rv (ATCC 27294) with MIC90 of 7.20 μM. 2-Mercaptopyridine N-oxide sodium and its complex with iron, gallium, and bismuth have good anti-M. tuberculosis activity. 2-Mercaptopyridine N-oxide sodium has potential for the treatment of tuberculosis .
loading...
    loading...
Cat. No.: HY-12485
CAS No.: 1257426-19-9
Purity:  99.74%
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

TBA-354 is a potent anti-tuberculosis compound; maintains activity against Mycobacterium tuberculosis H37Rv isogenic monoresistant strains.
loading...
    loading...
Cat. No.: HY-P11498
Research Areas:  

Infection

Cyclomarin monomer-2 (Compound 10), a cyclomarin monomer, is a pre-dimerization precursor that can form Homo-BacPROTACs targeting the degradation of ClpC1. Cyclomarin monomer-2 binds to the Mtb ClpC1 protein with a KD of 4.0 nM. The MIC of Cyclomarin monomer-2 against the Mtb H37Rv standard strain is 3.1 μM. Cyclomarin monomer-2 can be used as a key intermediate in the development of Homo-BacPROTACs .
loading...
    loading...
Cat. No.: HY-146158
CAS No.: 1859978-72-5
Synonyms: WX-081; Sudapyridine
Research Areas:  

Infection

Fudapirine, an anti-tuberculosis agent, displays excellent anti-mycobacterial activity against M. tuberculosis H37Rv and low cytotoxicity. Fudapirine exhibits potent activity with MIC50s of 0.083 and 0.11 μg/mL for agent susceptible tuberculosis (DS-TB) and multidrug resistant tuberculosis (MDR-TB) strains. Fudapirine also inhibits hERG channel with the IC50 of 1.89 μM.
loading...
    loading...
Cat. No.: HY-P11497
Research Areas:  

Infection

Cyclomarin monomer-1 (Compound 5), a cyclomarin monomer, is a pre-dimerization precursor that can form Homo-BacPROTACs targeting the degradation of ClpC1. Cyclomarin monomer-1 binds to the Mtb ClpC1 protein with a KD of 3.5 nM. The MIC of Cyclomarin monomer-1 against the Mtb H37Rv standard strain is 1.6 μM. Cyclomarin monomer-1 can be used as a key intermediate in the development of Homo-BacPROTACs .
loading...
    loading...
Cat. No.: HY-40156
CAS No.: 399-52-0
5-Fluoroindole is an orally active fluorinated indole derivative and antibacterial agent. 5-Fluoroindole induces ROS accumulation and triggers Apoptosis. 5-Fluoroindole inhibits the growth of pan-susceptible Mycobacterium tuberculosis (Mtb) H37Rv strains. 5-Fluoroindole has significant bactericidal activity against Pseudomonas syringae pv. actinidiae (Psa) with an EC50 of 15.34 μg/mL. 5-Fluoroindole introduces fluorine labeling for protein research. 5-Fluoroindole can be used in the study of tuberculosis and kiwifruit bacterial canker .
loading...
    loading...
Cat. No.: HY-129943
CAS No.: 20605-40-7
Purity:  99.59%
Target:  

Bacterial

Research Areas:  

Infection

Benzothiohydrazide is an analogue of anti–tubercular agent Isoniazid. Benzothiohydrazide exhibits anti–tubercular activity, with MICs of 132 μM and 264 μM for M. tuberculosis wild type (H37Rv) and clinical mutant strains (IC1 and IC2) .
loading...
    loading...
Cat. No.: HY-151204
CAS No.: 1447917-39-6
Target:  

Bacterial

Research Areas:  

Infection Inflammation/Immunology

PknB-IN-1 (Compound 2) is a protein kinase B (PknB) inhibitor (IC50=14.4 μM). PknB-IN-1 shows anti-mycobacterial activity, can inhibit M. tuberculosis H37Rv strain growth (MIC=6.2 μg/mL) .
loading...
    loading...
Cat. No.: HY-N11048
CAS No.: 2209112-96-7
Amycolatopsin A is a 20-membered macrolide, that can be isolated from a strain of the rare actinomycete Amycolatopsis sp. MST‐108494. Amycolatopsin A shows antimycobacterial activity against Mycobacterium bovis (BCG) and M. tuberculosis (H37Rv) with IC50 values of 0.4 µM and 4.4 µM, respectively .
loading...
    loading...
Cat. No.: HY-178436
Target:  

Bacterial

Research Areas:  

Infection

Antituberculosis agent-16 is an orally active antituberculosis agent. Antituberculosis agent-16 exhibits stable antituberculosis activity with a MIC of 0.48 μg/mL against Mycobacterium tuberculosis H37Rv sensitive strain and 0.49 μg/mL against multidrug-resistant strain 14862. Antituberculosis agent-16 shows high Caco-2 permeability. Antituberculosis agent-16 can be used for the research of infection .
loading...
    loading...
Cat. No.: HY-155190
CAS No.: 1357796-08-7
Target:  

Bacterial

Research Areas:  

Infection

Antitubercular agent-39 (Compound P1) is a potent antitubercular agent. Antitubercular agent-39 is active against drug-resistant strains and drug-susceptible clinical isolates. Antitubercular agent-39 inhibits Mtb strain H37Rv with a MIC less than 1 μM .
loading...
    loading...
Cat. No.: HY-149581
CAS No.: 2906099-98-5
Target:  

Bacterial

Research Areas:  

Infection

DprE1-IN-9 (compound B18) is an effective reversible DprE1 inhibitor and can bind to the receptor cavity of DprE1. DprE1-IN-9 shows strong antimycobacterial activity not only against non-pathogenic strain H37Ra (MIC=0.18 µg/mL) but also against pathogenic H37Rv and the clinical MDR and XDR isolates .
loading...
    loading...
Cat. No.: HY-126131
CAS No.: 2294013-78-6
Target:  

Bacterial

Research Areas:  

Infection

anti-TB agent 1 is a potent and orally active anti-tuberculosis agent, with MICs of < 2 nM against the Mtb strains H37Rv, rRMP and rINH .
loading...
    loading...
Cat. No.: HY-139596
CAS No.: 2221801-50-7
Target:  

Bacterial

Research Areas:  

Infection Inflammation/Immunology

Polyketide synthase 13-IN-3 (compound 41) is a polyketide synthase 13 inhibitor,with a MIC of 0.0625-0.125 μg/mL against the M. tuberculosis strain H37Rv .
loading...
    loading...
Cat. No.: HY-169108
Target:  

Bacterial

Research Areas:  

Infection

DprE1-IN-11 (compound 3) is an orally active DprE1 inhibitor with antituberculosis activity against MTB H37Rv and MDR-MTB strains (MIC <0.029-0.095 μM) .
loading...
    loading...
Cat. No.: HY-151205
CAS No.: 369606-71-3
Target:  

Bacterial

Research Areas:  

Infection Inflammation/Immunology

Antituberculosis agent-3 (Compound 2) is an antituberculosis agent. Antituberculosis agent-3 shows anti-mycobacterial activity, and can inhibit M. tuberculosis H37Rv strain growth (MIC=12.5 μg/mL) .
loading...
    loading...
Cat. No.: HY-115900
Target:  

Bacterial

Research Areas:  

Infection

Tuberculosis inhibitor 4 (compound 16), a mandelic acid-based spirothiazolidinone, has potent antimycobacterial activity against Mycobacterium tuberculosis strain H37Rv with the high inhibition value 98% at lower than 6.25 µg/mL concentration .
loading...
    loading...
Cat. No.: HY-146373
CAS No.: 2413006-48-9
Target:  

Bacterial

Research Areas:  

Infection

The minimum inhibitory concentration (MIC) of a new 2- (quinoline-4-methoxy) acetamide antituberculotic agent against the reference strain of Mycobacterium tuberculosis H37Rv was as low as 0.3 μ M. It also inhibited the growth of Mycobacterium tuberculosis in the macrophage model of tuberculosis infection.
loading...
    loading...